DE602006012310D1 - An titandioxidnanopartikeln absorbierte pharmazeutische wirkstoffe enthaltende pharmazeutische formulierungen - Google Patents
An titandioxidnanopartikeln absorbierte pharmazeutische wirkstoffe enthaltende pharmazeutische formulierungenInfo
- Publication number
- DE602006012310D1 DE602006012310D1 DE602006012310T DE602006012310T DE602006012310D1 DE 602006012310 D1 DE602006012310 D1 DE 602006012310D1 DE 602006012310 T DE602006012310 T DE 602006012310T DE 602006012310 T DE602006012310 T DE 602006012310T DE 602006012310 D1 DE602006012310 D1 DE 602006012310D1
- Authority
- DE
- Germany
- Prior art keywords
- pharmaceutical
- dioxide nanoparticles
- titanium dioxide
- pharmaceutical formulations
- activities
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5115—Inorganic compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Nanotechnology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Optics & Photonics (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68453205P | 2005-05-26 | 2005-05-26 | |
PCT/EP2006/003348 WO2006125496A2 (en) | 2005-05-26 | 2006-04-12 | Pharmaceutical formulations comprising active pharmaceutical principles absorbed on titanium dioxide nanoparticles |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602006012310D1 true DE602006012310D1 (de) | 2010-04-01 |
Family
ID=37452388
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602006012310T Expired - Fee Related DE602006012310D1 (de) | 2005-05-26 | 2006-04-12 | An titandioxidnanopartikeln absorbierte pharmazeutische wirkstoffe enthaltende pharmazeutische formulierungen |
Country Status (5)
Country | Link |
---|---|
US (1) | US20080206347A1 (de) |
EP (1) | EP1888046B1 (de) |
AT (1) | ATE457721T1 (de) |
DE (1) | DE602006012310D1 (de) |
WO (1) | WO2006125496A2 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5628480B2 (ja) | 2006-03-09 | 2014-11-19 | グラクソスミスクライン エルエルシー | 医薬成分を含有するコーティングカプセル |
WO2008135093A1 (en) * | 2007-05-08 | 2008-11-13 | Nm Tech Nanomaterials Microdevice Technology Ltd. | Products comprising an anti-microbial composition based on titanium dioxide nanoparticles |
FR2943539B1 (fr) * | 2009-03-31 | 2011-07-22 | Ethypharm Sa | Composition pharmaceutique comprenant un macrolide immunosuppresseur de la famille des limus. |
HUP1000299A2 (hu) | 2010-06-08 | 2012-02-28 | Nanoform Cardiovascular Therapeutics Ltd | Nanostrukturált Atorvastatint, gyógyszerészetileg elfogadott sóit és kokristályait tartalmazó készítmény és eljárás elõállításukra |
EP3084483A1 (de) | 2013-12-19 | 2016-10-26 | 3M Innovative Properties Company | Artikel mit selbstorganisierten schichten mit nanopartikeln mit einer phosphoroberflächenbehandlung |
CN110090305A (zh) * | 2019-03-15 | 2019-08-06 | 温州医科大学附属口腔医院 | 一种负载唑来膦酸的介孔二氧化钛 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2331097A1 (de) * | 1973-06-19 | 1975-01-16 | Battelle Institut E V | Depotsystem fuer pharmazeutische oder kosmetische praeparate mit retardwirkung fuer aeusserliche anwendung |
FR2451194A1 (fr) * | 1979-03-16 | 1980-10-10 | Merieux Inst | Nouveau medicament a base de ganglioside notamment pour le traitement du cholera, et compositions pharmaceutiques le contenant |
US6015801A (en) * | 1997-07-22 | 2000-01-18 | Merck & Co., Inc. | Method for inhibiting bone resorption |
US6086928A (en) * | 1998-02-05 | 2000-07-11 | Newly Weds Foods, Inc. | Whitened food products and process for producing the same |
ATE388691T1 (de) * | 2001-07-10 | 2008-03-15 | Univ North Carolina State | Träger zur freisetzung von nanopartikeln |
WO2003032959A1 (en) * | 2001-10-15 | 2003-04-24 | Bosch William H | Nanoparticulate compositions comprising inorganic cores |
EP1653927B1 (de) * | 2003-08-04 | 2012-01-11 | Bend Research, Inc. | Pharmazeutische zusammensetzungen von adsorbaten von amorphen arzneimitteln und lipophilen mikrophasen-bildenden materialien |
-
2006
- 2006-04-12 EP EP06724260A patent/EP1888046B1/de not_active Not-in-force
- 2006-04-12 DE DE602006012310T patent/DE602006012310D1/de not_active Expired - Fee Related
- 2006-04-12 AT AT06724260T patent/ATE457721T1/de not_active IP Right Cessation
- 2006-04-12 US US11/915,337 patent/US20080206347A1/en not_active Abandoned
- 2006-04-12 WO PCT/EP2006/003348 patent/WO2006125496A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
ATE457721T1 (de) | 2010-03-15 |
US20080206347A1 (en) | 2008-08-28 |
EP1888046B1 (de) | 2010-02-17 |
EP1888046A2 (de) | 2008-02-20 |
WO2006125496A3 (en) | 2007-04-12 |
WO2006125496A2 (en) | 2006-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CU20080052A7 (es) | Formas de presentación farmacéutica sólidas de administración oral con liberación rápida de principio activo | |
AP2012006231A0 (en) | Capsule formulation of pirfenidone and pharmaceutically acceptable excipients. | |
CA3094580C (en) | Oral formulations of cytidine analogs and methods of use thereof | |
IL195269A0 (en) | Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic | |
NO20080220L (no) | Formuleringer med hoy medikament belastning og doseringsformer | |
WO2011112229A3 (en) | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device | |
DK1957110T3 (da) | Fremgangsmåde til fremstilling af tygbare doseringsformer til lægemiddeladministration og produkter dermed | |
EP2444072A3 (de) | Nichtmukoadhäsive Filmdosierungsformen | |
ZA200800239B (en) | Mucosal or enteral administration of biobogically active macromolecules | |
ECSP088560A (es) | Formulacion de liberacion sostenida que comprende octreotida y dos o mas polimeros de polilactido-co-glicolido | |
MX2007002898A (es) | Tableta con liberacion gastrointestinal controlada en sitio y tiempo del ingrediente activo. | |
IL191804A0 (en) | Solid dispersion containing an active ingredient and tablets for oral administration containing the same | |
DE602006012310D1 (de) | An titandioxidnanopartikeln absorbierte pharmazeutische wirkstoffe enthaltende pharmazeutische formulierungen | |
FR2904219B1 (fr) | Microparticules a base de copolymere amphiphile et de principe(s) actif(s) a liberation modifiee et formulations pharmaceutiques en contenant | |
MY146988A (en) | Fexofenadine suspension formulation | |
IL195931A (en) | Oral Pharmaceutical Preparation with Controlled Release of Active Ingredient and Methods of Manufacturing | |
WO2011151722A3 (en) | Methods and compositions for oral pharmaceutical therapy | |
ATE498396T1 (de) | Pharmazeutische formulierung zur behandlung des oberen verdauungstraktes | |
IL201465A0 (en) | Self-precipitating pharmaceutical formulations for the modified release of active principle | |
ATE439832T1 (de) | Feste pharmazeutische arzneimittelformulierung enthaltend diacerein und meloxicam | |
NO20071806L (no) | Tabletter med steds- og tidsregulert gastrointestinal frigivelse av aktiv bestanddel. | |
HK1120417A1 (en) | Stable nanoparticle formulations | |
ITMI20051231A1 (it) | Formulazioni farmaceutiche contenenti colostro e calcio folinato per il trattamento delle affezioni del cavo orale | |
ECSP109871A (es) | Soluciones farmacéuticas orales que contienen telbivudina | |
BRPI0810878A2 (pt) | Partículas à base de polieletrólitos e de princípio ativo de liberação modificada e formulações farmacêuticas contendo estas partículas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8339 | Ceased/non-payment of the annual fee |